Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université du Québec à Montréal

$35,000.00

Probing the molecular mechanisms of action of class B G protein-coupled receptor peptide ligands: a multidisciplinary study.

EF 2012-13

Résumé
Peptides are an important class of biological macromolecules that regulate key physiological processes by acting as neurotransmitters, neurohormones, hormones, growth factors or antibiotics. Owing to the large array of functions and high specificity and potency of peptides, the development of peptide-based therapeutic and diagnostic tools has received an increased interest, demanding for a better understanding of their mechanisms of action at the molecular level. To perform its biological function(s), a polypeptide chain needs to fold into a very specific three-dimensional structure, known as the bioactive structure, allowing the precise positioning of its pharmacophoric elements. However, numerous endogenous peptides are natively disordered; i.e. they exhibit a random coil structure in solution. It is not understood, in the context of a complex biological system, how the conformational shift of a peptide from a random coil into a well-defined biologically active conformation is performed. This lack of knowledge constitutes a major drawback for the use of peptide as therapeutics. The overarching goals of this research program are to elucidate how the biochemical microenvironment and the molecular interactome influence the conformational landscape of intrinsically disordered peptides and to develop innovative peptide-based therapeutics and chemical tools. We are particularly interested in a homogenous family of peptide hormones, which through specific binding to membrane-bound receptor regulate important physiological responses, such as central nervous system ontogenesis, food intake and blood pressure. Whereas most of the past attention in peptide drug design has been focusing on the elucidation of the bioactive conformation, the significance and the impact of the interactions between the peptidic ligands and the cell surface microenvironment have not been addressed. This program will redefine the roles of transient binding partners in the biological activity of these natively disordered peptide hormones. Our results could lead to the development of a new class of molecules having therapeutic potential for the treatment of various diseases such as autism, osteoporosis and neurological insults.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
418614-2012
Name nom
Bourgault, Steve
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
5
Application title
Probing the molecular mechanisms of action of class B G protein-coupled receptor peptide ligands: a multidisciplinary study.
Keyword
NSERC
Application summary
Peptides are an important class of biological macromolecules that regulate key physiological processes by acting as neurotransmitters, neurohormones, hormones, growth factors or antibiotics. Owing to the large array of functions and high specificity and potency of peptides, the development of peptide-based therapeutic and diagnostic tools has received an increased interest, demanding for a better understanding of their mechanisms of action at the molecular level. To perform its biological function(s), a polypeptide chain needs to fold into a very specific three-dimensional structure, known as the bioactive structure, allowing the precise positioning of its pharmacophoric elements. However, numerous endogenous peptides are natively disordered; i.e. they exhibit a random coil structure in solution. It is not understood, in the context of a complex biological system, how the conformational shift of a peptide from a random coil into a well-defined biologically active conformation is performed. This lack of knowledge constitutes a major drawback for the use of peptide as therapeutics. The overarching goals of this research program are to elucidate how the biochemical microenvironment and the molecular interactome influence the conformational landscape of intrinsically disordered peptides and to develop innovative peptide-based therapeutics and chemical tools. We are particularly interested in a homogenous family of peptide hormones, which through specific binding to membrane-bound receptor regulate important physiological responses, such as central nervous system ontogenesis, food intake and blood pressure. Whereas most of the past attention in peptide drug design has been focusing on the elucidation of the bioactive conformation, the significance and the impact of the interactions between the peptidic ligands and the cell surface microenvironment have not been addressed. This program will redefine the roles of transient binding partners in the biological activity of these natively disordered peptide hormones. Our results could lead to the development of a new class of molecules having therapeutic potential for the treatment of various diseases such as autism, osteoporosis and neurological insults.